Home/Filings/4/0001104659-25-061277
4//SEC Filing

Shah Nimish P 4

Accession 0001104659-25-061277

CIK 0001974640other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 8:05 PM ET

Size

6.6 KB

Accession

0001104659-25-061277

Insider Transaction Report

Form 4
Period: 2025-06-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-17+14,46114,461 total
    Exercise: $41.66Exp: 2035-06-17Common Stock (14,461 underlying)
Footnotes (2)
  • [F1]This option represents the right to purchase 14,461 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date.
  • [F2]Under an agreement between the Reporting Person and VR Management, LLC (the "Management Company"), the Reporting Person is deemed to hold the reported option and the shares underlying the option for the sole benefit of the Management Company and must exercise the reported option solely upon the direction of the Management Company, which is entitled to the shares underlying the option. The Management Company may be deemed the indirect beneficial owner of the shares underlying the option, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares underlying the option through his interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

Issuer

Apogee Therapeutics, Inc.

CIK 0001974640

Entity typeother

Related Parties

1
  • filerCIK 0001698082

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 8:05 PM ET
Size
6.6 KB